BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20395662)

  • 1. Hypothalamic dysfunction in a female with isolated hypogonadotropic hypogonadism and compound heterozygous TACR3 mutations and clinical manifestation in her heterozygous mother.
    Fukami M; Maruyama T; Dateki S; Sato N; Yoshimura Y; Ogata T
    Horm Res Paediatr; 2010; 73(6):477-81. PubMed ID: 20395662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans.
    Young J; Bouligand J; Francou B; Raffin-Sanson ML; Gaillez S; Jeanpierre M; Grynberg M; Kamenicky P; Chanson P; Brailly-Tabard S; Guiochon-Mantel A
    J Clin Endocrinol Metab; 2010 May; 95(5):2287-95. PubMed ID: 20194706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood.
    Gianetti E; Tusset C; Noel SD; Au MG; Dwyer AA; Hughes VA; Abreu AP; Carroll J; Trarbach E; Silveira LF; Costa EM; de Mendonça BB; de Castro M; Lofrano A; Hall JE; Bolu E; Ozata M; Quinton R; Amory JK; Stewart SE; Arlt W; Cole TR; Crowley WF; Kaiser UB; Latronico AC; Seminara SB
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2857-67. PubMed ID: 20332248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations.
    Francou B; Bouligand J; Voican A; Amazit L; Trabado S; Fagart J; Meduri G; Brailly-Tabard S; Chanson P; Lecomte P; Guiochon-Mantel A; Young J
    PLoS One; 2011; 6(10):e25614. PubMed ID: 22031817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness to a physiological regimen of GnRH therapy and relation to genotype in women with isolated hypogonadotropic hypogonadism.
    Abel BS; Shaw ND; Brown JM; Adams JM; Alati T; Martin KA; Pitteloud N; Seminara SB; Plummer L; Pignatelli D; Crowley WF; Welt CK; Hall JE
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E206-16. PubMed ID: 23341491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of gene defects underlying isolated hypogonadotropic hypogonadism in patients with constitutional delay of growth and puberty.
    Vaaralahti K; Wehkalampi K; Tommiska J; Laitinen EM; Dunkel L; Raivio T
    Fertil Steril; 2011 Jun; 95(8):2756-8. PubMed ID: 21292259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel severe N-terminal splice site KISS1R gene mutation causes hypogonadotropic hypogonadism but enables a normal development of neonatal external genitalia.
    Breuer O; Abdulhadi-Atwan M; Zeligson S; Fridman H; Renbaum P; Levy-Lahad E; Zangen DH
    Eur J Endocrinol; 2012 Aug; 167(2):209-16. PubMed ID: 22619348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction.
    Costa EM; Bedecarrats GY; Mendonca BB; Arnhold IJ; Kaiser UB; Latronico AC
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2680-6. PubMed ID: 11397871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of TAC3 and TACR3 genes in patients with idiopathic central pubertal disorders.
    Tusset C; Noel SD; Trarbach EB; Silveira LF; Jorge AA; Brito VN; Cukier P; Seminara SB; Mendonça BB; Kaiser UB; Latronico AC
    Arq Bras Endocrinol Metabol; 2012 Dec; 56(9):646-52. PubMed ID: 23329188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype-phenotype relationships.
    Brioude F; Bouligand J; Trabado S; Francou B; Salenave S; Kamenicky P; Brailly-Tabard S; Chanson P; Guiochon-Mantel A; Young J
    Eur J Endocrinol; 2010 May; 162(5):835-51. PubMed ID: 20207726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of KISS1 Receptor mutations in a series of 603 patients with normosmic congenital hypogonadotrophic hypogonadism and characterization of novel mutations: a single-centre study.
    Francou B; Paul C; Amazit L; Cartes A; Bouvattier C; Albarel F; Maiter D; Chanson P; Trabado S; Brailly-Tabard S; Brue T; Guiochon-Mantel A; Young J; Bouligand J
    Hum Reprod; 2016 Jun; 31(6):1363-74. PubMed ID: 27094476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of gonadotropin-releasing hormone receptor mutations in a large cohort of patients with hypogonadotropic hypogonadism.
    Bhagavath B; Ozata M; Ozdemir IC; Bolu E; Bick DP; Sherins RJ; Layman LC
    Fertil Steril; 2005 Oct; 84(4):951-7. PubMed ID: 16213849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of sequence variations of the GnRH receptor and G protein-coupled receptor 54 gene in male idiopathic hypogonadotropic hypogonadism.
    Lanfranco F; Gromoll J; von Eckardstein S; Herding EM; Nieschlag E; Simoni M
    Eur J Endocrinol; 2005 Dec; 153(6):845-52. PubMed ID: 16322390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal embryonic LHRH factor (NELF) mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
    Xu N; Kim HG; Bhagavath B; Cho SG; Lee JH; Ha K; Meliciani I; Wenzel W; Podolsky RH; Chorich LP; Stackhouse KA; Grove AM; Odom LN; Ozata M; Bick DP; Sherins RJ; Kim SH; Cameron RS; Layman LC
    Fertil Steril; 2011 Apr; 95(5):1613-20.e1-7. PubMed ID: 21300340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated cryptorchidism: no evidence for involvement of genes underlying isolated hypogonadotropic hypogonadism.
    Laitinen EM; Tommiska J; Virtanen HE; Oehlandt H; Koivu R; Vaaralahti K; Toppari J; Raivio T
    Mol Cell Endocrinol; 2011 Jul; 341(1-2):35-8. PubMed ID: 21664240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
    Quaynor SD; Kim HG; Cappello EM; Williams T; Chorich LP; Bick DP; Sherins RJ; Layman LC
    Fertil Steril; 2011 Dec; 96(6):1424-1430.e6. PubMed ID: 22035731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurokinin B and its receptor in hypogonadotropic hypogonadism.
    Semple RK; Topaloglu AK
    Front Horm Res; 2010; 39():133-141. PubMed ID: 20389091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three Siblings with Idiopathic Hypogonadotropic Hypogonadism in a Nonconsanguineous Family: A Novel
    Nalbantoğlu Ö; Arslan G; Köprülü Ö; Hazan F; Gürsoy S; Özkan B
    J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):444-448. PubMed ID: 30905142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new compound heterozygous mutation of the gonadotropin-releasing hormone receptor (L314X, Q106R) in a woman with complete hypogonadotropic hypogonadism: chronic estrogen administration amplifies the gonadotropin defect.
    Kottler ML; Chauvin S; Lahlou N; Harris CE; Johnston CJ; Lagarde JP; Bouchard P; Farid NR; Counis R
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3002-8. PubMed ID: 10999776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction.
    Topaloglu AK; Reimann F; Guclu M; Yalin AS; Kotan LD; Porter KM; Serin A; Mungan NO; Cook JR; Imamoglu S; Akalin NS; Yuksel B; O'Rahilly S; Semple RK
    Nat Genet; 2009 Mar; 41(3):354-358. PubMed ID: 19079066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.